68,983 Shares in Nu Skin Enterprises, Inc. (NYSE:NUS) Bought by Centiva Capital LP

Centiva Capital LP purchased a new position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 68,983 shares of the company's stock, valued at approximately $508,000. Centiva Capital LP owned 0.14% of Nu Skin Enterprises at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Pacer Advisors Inc. purchased a new stake in shares of Nu Skin Enterprises in the second quarter valued at $25,230,000. Federated Hermes Inc. boosted its position in shares of Nu Skin Enterprises by 111.8% during the second quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company's stock valued at $13,950,000 after buying an additional 698,722 shares during the period. Millennium Management LLC grew its stake in shares of Nu Skin Enterprises by 100.5% during the second quarter. Millennium Management LLC now owns 534,579 shares of the company's stock valued at $5,634,000 after buying an additional 267,965 shares during the last quarter. Walleye Capital LLC lifted its stake in shares of Nu Skin Enterprises by 335.3% during the 3rd quarter. Walleye Capital LLC now owns 289,236 shares of the company's stock worth $2,132,000 after acquiring an additional 222,793 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Nu Skin Enterprises by 91.8% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 271,885 shares of the company's stock valued at $2,004,000 after acquiring an additional 130,164 shares during the period. 82.84% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Stock Performance

Shares of NYSE NUS traded up $0.29 during midday trading on Monday, reaching $7.79. The company had a trading volume of 596,496 shares, compared to its average volume of 843,867. The stock has a market cap of $386.99 million, a P/E ratio of -3.76 and a beta of 1.20. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. Nu Skin Enterprises, Inc. has a 1 year low of $5.95 and a 1 year high of $20.75. The business's 50-day simple moving average is $6.84 and its 200 day simple moving average is $9.06.

Nu Skin Enterprises Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th will be paid a $0.06 dividend. The ex-dividend date is Friday, November 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.08%. Nu Skin Enterprises's payout ratio is currently -11.59%.

Analyst Upgrades and Downgrades

NUS has been the topic of a number of recent research reports. DA Davidson dropped their price target on Nu Skin Enterprises from $12.50 to $11.00 and set a "neutral" rating on the stock in a research report on Monday, August 12th. StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Monday, November 11th. Finally, Citigroup cut their price objective on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating on the stock in a report on Tuesday, October 22nd.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.